We then focused on breast cancer samples with PIK3CA mutations and observed that PIK3CA-mutant patients with high CDKN1A expression were associated with poorer overall patients survival compared to patients with mutant PI3K but lower CDKN1A levels (Fig. 4e). This evidence concerns the gene CDKN1A and breast cancer.